Digoxin combined with Premarin

Reports:


Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Ventricular Dysfunction Hospitalization 1/1/2000 58 Female 181 lb 1/17/2006 Physician United States
Primary
Concomitant
Retinitis Pigmentosa Other Serious 1/1/2005 51 Female 143 lb 1/11/2006 Other Health Professional United States
Primary
Concomitant
Retinitis Pigmentosa Other Serious 1/1/2005 51 Female 143 lb 1/13/2006 Other Health Professional United States
Primary
Concomitant
Retinitis Pigmentosa Other Serious 1/1/2005 51 Female 143 lb 2/8/2006 Physician United States
Primary
Concomitant
Hepatic Neoplasm Malignant Death Female 2/24/2006 Physician United States
Primary
Concomitant
Sleep Apnoea Syndrome Other Serious 5/1/2000 53 Female 181 lb 4/7/2006 Lawyer United States
Primary
Concomitant
Myocardial Infarction Hospitalization 12/4/2003 63 Female 154 lb 4/10/2006 Lawyer United States
Primary
Concomitant
International Normalised Ratio Increased Hospitalization 1/11/2006 79 Female 106 lb 3/27/2006 Pharmacist United States
Primary
Secondary
Concomitant
Sleep Apnoea Syndrome Hospitalization 4/4/2001 56 Female 273 lb 4/18/2006 Physician United States
Primary
Concomitant
Tremor Hospitalization 1/1/2000 58 Female 181 lb 5/10/2006 Physician United States
Primary
Concomitant
Transient Ischaemic Attack Other Serious 12/14/2002 67 Female 220 lb 5/11/2006 Physician United States
Primary
Concomitant
Renal Artery Stenosis Hospitalization 11/15/2005 Female 5/12/2006 Physician United States
Primary
Concomitant
Pharmaceutical Product Complaint Other Serious 3/31/2006 Female 5/4/2006 Consumer United States
Primary
Concomitant
Hair Texture Abnormal 1/1/2003 Female 7/3/2006 Consumer United States
Primary
Secondary
Concomitant
Palpitations 5/1/2006 72 Female 7/6/2006 Consumer United States
Primary
Concomitant
Sinus Tachycardia Other Serious 61 Female 132 lb 7/26/2006 Physician Switzerland
Primary
Concomitant
Osteonecrosis Other Serious 1/1/2006 79 Female 88 lb 8/3/2006 Physician United States
Primary
Secondary
Concomitant
Nodal Arrhythmia Life Threatening 4/26/2006 Female 205 lb 10/5/2006 Pharmacist United States
Primary
Secondary
Concomitant
Skin Fissures Other Serious 10/5/2006 Female 155 lb 10/6/2006 Other Health Professional United States
Primary
Concomitant
Myocardial Infarction Other Serious Female 10/9/2006 Physician Canada
Primary
Concomitant
Muscular Weakness Other Serious 11/18/2006 79 Female 11/21/2006 Consumer United States
Primary
Concomitant
Surgery Other Serious Female 12/4/2006 Physician Canada
Primary
Concomitant
Fatigue 9/1/2006 85 Female 11/7/2006 Consumer United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 3/1/2006 Female 97 lb 4/11/2006 Pharmacist United States
Primary
Concomitant
Therapeutic Agent Toxicity Other Serious 73 Female 1/30/2007 Consumer United States
Primary
Secondary
Concomitant
Osteonecrosis Other Serious 1/1/2006 79 Female 88 lb 2/5/2007 Physician United States
Primary
Secondary
Concomitant
Peripheral Vascular Disorder Other Serious 61 Female 2/16/2007 Pharmacist Canada
Primary
Concomitant
Skin Fissures Other Serious 10/5/2006 Female 154 lb 2/28/2007 Other Health Professional United States
Primary
Concomitant
Pharmaceutical Product Complaint Other Serious 1/19/2007 63 Female 143 lb 3/15/2007 Consumer United States
Primary
Concomitant
Therapeutic Agent Toxicity Other Serious 73 Female 3/21/2007 Consumer United States
Primary
Secondary
Concomitant
Pharmaceutical Product Complaint Other Serious 1/19/2007 63 Female 143 lb 4/3/2007 Consumer United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 73 Female 108 lb 6/5/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Hospitalization 73 Female 108 lb 6/12/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Tubal Ligation Other Serious 1/1/1993 55 Female 155 lb 8/3/2007 Lawyer United States
Primary
Secondary
Concomitant
Vomiting Hospitalization 68 Female 11/5/2007 United States
Primary
Secondary
Concomitant
Staphylococcal Infection Hospitalization 7/31/2006 Female 133 lb 12/6/2007 Physician United States
Primary
Concomitant
Vomiting Life Threatening 12/10/2007 Female 110 lb 12/23/2007 Physician United States
Primary
Concomitant
Drug Ineffective Female 1/14/2008 Consumer United States
Primary
Concomitant
Pulmonary Oedema Hospitalization 12/13/2007 Female 1/15/2008 Consumer United States
Primary
Concomitant
Malaise Other Serious 8/1/2007 65 Female 229 lb 1/29/2008 Physician United States
Primary
Concomitant
Vision Blurred Other Serious 1/1/2007 Female 3/5/2008 Consumer United States
Primary
Concomitant
Malaise Other Serious 8/1/2007 65 Female 229 lb 3/7/2008 Consumer United States
Primary
Concomitant
Death Hospitalization 2/27/2008 Female 140 lb 3/14/2008 Pharmacist United States
Primary
Concomitant
Angioedema Other Serious 2/21/2008 Female 140 lb 3/19/2008 Pharmacist United States
Primary
Concomitant
Injection Site Irritation 1/1/2008 49 Female 161 lb 4/16/2008 United States
Primary
Concomitant
Sinus Tachycardia Hospitalization 64 Female 5/28/2008 United States
Primary
Concomitant
Vertebral Injury Other Serious 1/1/2003 68 Female 6/25/2008 Consumer United States
Primary
Concomitant
Squamous Cell Carcinoma Of Skin Other Serious 1/1/1993 Female 155 lb 7/10/2008 Lawyer United States
Primary
Secondary
Concomitant
Interacting
Vertigo Hospitalization 4/20/2008 51 Female 185 lb 7/14/2008 United States
Primary
Concomitant
Weight Decreased Other Serious 1/1/2003 Female 105 lb 7/24/2008 Consumer Canada
Primary
Concomitant
Trance Hospitalization 12/1/2006 64 Female 8/4/2008 Consumer United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2003 Female 105 lb 9/4/2008 Physician Canada
Primary
Concomitant
Vasospasm Other Serious 10/16/1995 Female 167 lb 9/10/2008 United States
Primary
Secondary
Concomitant
Vocal Cord Disorder Other Serious 10/16/1995 Female 167 lb 9/23/2008 United States
Primary
Secondary
Concomitant
Renal Failure Hospitalization 4/30/2008 71 Female 200 lb 12/12/2008 United States
Primary
Concomitant
Vocal Cord Disorder Other Serious 10/16/1995 Female 167 lb 12/19/2008 United States
Primary
Secondary
Concomitant
Serotonin Syndrome Other Serious 8/1/2008 74 Female 105 lb 12/15/2008 Physician United States
Primary
Concomitant
Blood Glucose Increased 11/27/2008 Female 2/24/2009 United States
Primary
Concomitant
Oedema Peripheral Other Serious 1/1/2004 57 Female 110 lb 3/4/2009 Physician United States
Primary
Concomitant
Breast Cancer Female Other Serious 5/1/2004 Female 130 lb 4/9/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/1999 Female 209 lb 4/9/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/25/1998 Female 141 lb 4/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Pulmonary Embolism Other Serious 11/1/1995 Female 134 lb 4/27/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/3/2001 Female 4/29/2009 Lawyer United States
Primary
Secondary
Concomitant
Surgery Other Serious Female 4/30/2009 Physician United States
Primary
Concomitant
Thrombosis Required Intervention 57 Female 5/12/2009 United States
Primary
Concomitant
Cataract Other Serious 5/1/2007 Female 5/18/2009 Consumer United States
Primary
Secondary
Concomitant
Injury Hospitalization 64 Female 5/13/2009 Lawyer United States
Primary
Concomitant
Breast Cancer Other Serious 3/12/2001 Female 5/25/2009 Lawyer United States
Primary
Secondary
Concomitant
Palpitations Hospitalization 4/1/2009 Female 148 lb 5/20/2009 Pharmacist United States
Primary
Concomitant
Breast Cancer Other Serious 2/10/1999 Female 117 lb 6/5/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 9/26/2001 Female 170 lb 6/9/2009 Lawyer United States
Primary
Secondary
Concomitant
Vitamin B12 Deficiency Hospitalization 73 Female 6/7/2009 Lawyer United States
Primary
Concomitant
Oestrogen Receptor Assay Positive Other Serious 5/13/1998 Female 134 lb 6/18/2009 Consumer United States
Primary
Secondary
Concomitant
Vertigo Death 74 Female 6/14/2009 United States
Primary
Concomitant
Quality Of Life Decreased Hospitalization 78 Female 6/14/2009 United States
Primary
Concomitant
Visual Acuity Reduced Other Serious 1/1/2008 Female 108 lb 6/24/2009 Physician United States
Primary
Concomitant
Breast Cancer Female Other Serious 7/23/1997 Female 6/24/2009 Lawyer United States
Primary
Secondary
Concomitant
Vision Blurred Hospitalization 84 Female 6/19/2009 United States
Primary
Concomitant
Vitamin B12 Deficiency Hospitalization 73 Female 6/23/2009 United States
Primary
Concomitant
Mental Disorder Hospitalization 64 Female 6/29/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 75 Female 7/1/2009 Lawyer United States
Primary
Concomitant
Vertigo Hospitalization 66 Female 7/1/2009 Lawyer United States
Primary
Concomitant
Palpitations Hospitalization 83 Female 170 lb 7/2/2009 United States
Primary
Concomitant
Weight Decreased Hospitalization 72 Female 7/2/2009 United States
Primary
Concomitant
Wound Secretion Hospitalization 62 Female 7/12/2009 United States
Primary
Concomitant
Ventricular Fibrillation Hospitalization 64 Female 7/13/2009 United States
Primary
Concomitant
Breast Cancer Female Other Serious 11/2/2001 Female 154 lb 7/20/2009 Lawyer United States
Primary
Secondary
Concomitant
Trigger Finger Other Serious 5/1/2007 Female 7/20/2009 Physician United States
Primary
Secondary
Concomitant
Social Problem Death 81 Female 7/14/2009 United States
Primary
Concomitant
Injury Death 72 Female 7/14/2009 United States
Primary
Concomitant
Weight Decreased Hospitalization 62 Female 7/19/2009 Lawyer United States
Primary
Concomitant
Social Avoidant Behaviour Death 80 Female 7/20/2009 United States
Primary
Concomitant
Weight Decreased Hospitalization 62 Female 7/22/2009 Lawyer United States
Primary
Concomitant
Vomiting Hospitalization 72 Female 7/22/2009 Lawyer United States
Primary
Concomitant
Vomiting Other Serious 3/18/2008 56 Female 258 lb 7/22/2009 United States
Primary
Concomitant
Vomiting Hospitalization 79 Female 7/22/2009 United States
Primary
Concomitant
Weight Decreased Hospitalization 4/26/2008 85 Female 8/3/2009 Lawyer United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 75 Female 8/3/2009 United States
Primary
Concomitant
Urinary Tract Infection Hospitalization 72 Female 7/30/2009 United States
Primary
Concomitant
Weight Decreased Death 75 Female 7/31/2009 Lawyer United States
Primary
Concomitant
Breast Cancer Female Other Serious 2/7/2003 Female 154 lb 8/11/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 9/8/2002 Female 110 lb 8/11/2009 Consumer United States
Primary
Secondary
Concomitant
Therapeutic Agent Toxicity Other Serious 3/18/2008 56 Female 258 lb 8/6/2009 Lawyer United States
Primary
Concomitant
Vomiting Hospitalization 12/6/2007 72 Female 8/5/2009 United States
Primary
Concomitant
Unevaluable Event Death 72 Female 8/10/2009 United States
Primary
Concomitant
Weight Decreased Hospitalization 4/26/2008 85 Female 8/10/2009 Lawyer United States
Primary
Concomitant
Vision Blurred Other Serious 4/23/2007 54 Female 258 lb 8/12/2009 United States
Primary
Concomitant
Breast Cancer Other Serious 3/12/2001 Female 8/20/2009 Lawyer United States
Primary
Secondary
Concomitant
Visual Acuity Reduced Hospitalization 83 Female 8/17/2009 Lawyer United States
Primary
Concomitant
Weight Decreased Hospitalization 72 Female 8/14/2009 United States
Primary
Concomitant
Urinary Tract Infection Hospitalization Female 8/18/2009 Lawyer United States
Primary
Concomitant
Vertigo Hospitalization 74 Female 8/18/2009 United States
Primary
Concomitant
White Blood Cell Count Increased Hospitalization 53 Female 8/27/2009 United States
Primary
Concomitant
Weight Decreased Hospitalization 4/26/2008 85 Female 8/26/2009 United States
Primary
Concomitant
Unevaluable Event Hospitalization 78 Female 8/26/2009 United States
Primary
Concomitant
Weight Decreased Hospitalization 62 Female 8/26/2009 United States
Primary
Concomitant
Quality Of Life Decreased Hospitalization 78 Female 8/31/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 75 Female 8/31/2009 Lawyer United States
Primary
Concomitant
Thyroxine Free Increased Other Serious 4/23/2007 54 Female 258 lb 9/2/2009 Lawyer United States
Primary
Concomitant
Vertigo Hospitalization 1/1/2009 78 Female 154 lb 9/10/2009 Other Health Professional Canada
Primary
Secondary
Concomitant
Vision Blurred Life Threatening 55 Female 9/4/2009 United States
Primary
Concomitant
Weight Increased Other Serious 4/23/2007 54 Female 258 lb 9/3/2009 United States
Primary
Concomitant
Vertigo Hospitalization 74 Female 9/2/2009 United States
Primary
Concomitant
Surgery Other Serious Female 9/3/2009 Lawyer United States
Primary
Concomitant
Breast Cancer Female Other Serious 6/1/2003 Female 9/11/2009 Consumer United States
Primary
Secondary
Concomitant
White Blood Cell Count Increased Hospitalization 53 Female 9/11/2009 United States
Primary
Concomitant
Palpitations Hospitalization 78 Female 9/16/2009 United States
Primary
Concomitant
Obesity 5/1/2002 50 Female 145 lb 9/26/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Hospitalization 64 Female 155 lb 9/17/2009 United States
Primary
Concomitant
Vertigo Hospitalization 74 Female 9/23/2009 Lawyer United States
Primary
Concomitant
Urinary Tract Infection Hospitalization Female 9/21/2009 United States
Primary
Concomitant
White Blood Cell Count Increased Hospitalization 53 Female 9/29/2009 United States
Primary
Concomitant
Visual Acuity Reduced Hospitalization 83 Female 9/28/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Required Intervention 64 Female 155 lb 9/24/2009 United States
Primary
Concomitant
Quality Of Life Decreased Hospitalization 78 Female 9/25/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Other Serious 46 Female 223 lb 9/25/2009 United States
Primary
Concomitant
Wheezing Life Threatening 55 Female 9/24/2009 United States
Primary
Concomitant
Urinary Tract Infection Other Serious 4/23/2007 54 Female 258 lb 9/24/2009 United States
Primary
Concomitant
Urinary Tract Infection Hospitalization 80 Female 9/21/2009 United States
Primary
Concomitant
Visual Impairment Other Serious 54 Female 9/25/2009 United States
Primary
Concomitant
White Blood Cell Count Increased Hospitalization 60 Female 9/29/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Required Intervention 64 Female 10/12/2009 United States
Primary
Concomitant
Vertigo Hospitalization 66 Female 10/10/2009 United States
Primary
Concomitant
Vision Blurred Life Threatening 55 Female 10/16/2009 United States
Primary
Concomitant
Vertigo Hospitalization 66 Female 10/16/2009 United States
Primary
Concomitant
Therapeutic Agent Toxicity Other Serious 46 Female 492 lb 10/16/2009 United States
Primary
Concomitant
Urinary Tract Infection Hospitalization 80 Female 10/16/2009 Lawyer United States
Primary
Concomitant
Surgery Other Serious Female 10/16/2009 Lawyer United States
Primary
Concomitant
Right Ventricular Systolic Pressure Increased Other Serious 84 Female 10/16/2009 Lawyer United States
Primary
Concomitant